carbamazepine has been researched along with inositol in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 9 (50.00) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Logan, SD; McDermott, EE | 1 |
| Bosch, X; Esmatjes, E; Goday, A; Gomis, R; Nubiola, A; Vendrell, J; Vilardell, E | 1 |
| Lenox, RH; McNamara, RK; Watson, DG; Watterson, JM | 1 |
| Chuang, DM; Katsube, N; Nonaka, S | 1 |
| Lubrich, B; van Calker, D | 1 |
| Belmaker, RH; Bersudsky, Y; Hertz, L; Simkin, M; Wolfson, M; Zinger, E | 1 |
| Belmaker, RH; van Calker, D | 1 |
| Buttenfield, J; Chengappa, KN; Gershon, S; Hardan, A; Kupfer, DJ; Levine, J; Luther, J; Mallinger, AG; Pollock, B; Vagnucci, A; Verfaille, S | 1 |
| Agam, G; Harwood, AJ | 1 |
| Basta-Kaim, A; Budziszewska, B; Jaworska-Feil, L; Kubera, M; Lasoń, W; Leśkiewicz, M; Tetich, M | 1 |
| Greenshaw, AJ; McGrath, BM; McKay, R; Silverstone, PH; Slupsky, CM | 1 |
| Dalton, E; Harwood, AJ; King, J; Ryves, J; Teo, R; Williams, RS | 1 |
| Di Daniel, E; Kew, JN; Maycox, PR | 1 |
| Anderson, KE; Basaraba, R; Brown, K; Burgon, J; Coulter, S; Fleming, A; Floto, RA; Hawkins, PT; Hegyi, K; Henao Tamayo, M; Henry, KM; Hepburn, L; Kampmann, B; Kay, RR; Klapholz, C; Newton, SM; Obregón-Henao, A; Ordway, DJ; Renna, M; Renshaw, SA; Rubinsztein, DC; Schiebler, M | 1 |
3 review(s) available for carbamazepine and inositol
| Article | Year |
|---|---|
The high affinity inositol transport system--implications for the pathophysiology and treatment of bipolar disorder.
Topics: Antimanic Agents; Biological Transport, Active; Bipolar Disorder; Carbamazepine; Carrier Proteins; Down-Regulation; Heat-Shock Proteins; Humans; Inositol; Lithium Compounds; Membrane Proteins; Symporters; Valproic Acid | 2000 |
Search for a common mechanism of mood stabilizers.
Topics: Affect; Animals; Anticonvulsants; Antimanic Agents; Carbamazepine; Glycogen Synthase Kinase 3; Humans; Inositol; Lithium; Mood Disorders; Signal Transduction; Valproic Acid | 2003 |
Investigation of the H(+)-myo-inositol transporter (HMIT) as a neuronal regulator of phosphoinositide signalling.
Topics: Animals; Antimanic Agents; Brain; Carbamazepine; Glucose Transport Proteins, Facilitative; Humans; Inositol; Lithium Compounds; Membrane Transport Proteins; Neurons; Phosphatidylinositols; Signal Transduction; Valproic Acid | 2009 |
1 trial(s) available for carbamazepine and inositol
| Article | Year |
|---|---|
Inositol as an add-on treatment for bipolar depression.
Topics: Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Blood-Brain Barrier; Carbamazepine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Inositol; Lithium; Male; Middle Aged; Pilot Projects; Treatment Outcome; Valproic Acid | 2000 |
14 other study(ies) available for carbamazepine and inositol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Inhibition of agonist-stimulated inositol lipid metabolism by the anticonvulsant carbamazepine in rat hippocampus.
Topics: Animals; Carbachol; Carbamazepine; Hippocampus; Histamine; In Vitro Techniques; Inositol; Lipid Metabolism; Male; Phenytoin; Rats; Rats, Inbred Strains; Sodium Channels; Tetrodotoxin; Veratrine | 1989 |
Erythromelalgia associated with acute diabetic neuropathy: an unusual condition.
Topics: Acute Disease; Adult; Carbamazepine; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Erythromelalgia; Humans; Imipramine; Inositol; Male; Pain | 1988 |
Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Topics: Animals; Bipolar Disorder; Blotting, Western; Carbamazepine; Cell Line; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Gene Expression; Hippocampus; Humans; Inositol; Intracellular Signaling Peptides and Proteins; Lithium Chloride; Membrane Proteins; Myristoylated Alanine-Rich C Kinase Substrate; Neurons; Protein Biosynthesis; Protein Kinase C; Proteins; Rabbits; Rats; Valproic Acid | 1996 |
Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine.
Topics: 5'-Nucleotidase; Animals; Anticonvulsants; Carbamazepine; Cells, Cultured; Cerebellum; Inositol; Lithium; Neuroprotective Agents; Phenytoin; Phosphatidylinositol 3-Kinases; Potassium; Rats; Rats, Sprague-Dawley | 1998 |
Inhibition of the high affinity myo-inositol transport system: a common mechanism of action of antibipolar drugs?
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Animals; Antimanic Agents; Astrocytes; Biological Transport; Brain; Carbamazepine; Carrier Proteins; Heat-Shock Proteins; Humans; Inositol; Lithium; Membrane Proteins; Rats; Rats, Wistar; RNA, Messenger; Symporters; Time Factors; Tumor Cells, Cultured; Valproic Acid | 1999 |
Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations.
Topics: Antimanic Agents; Astrocytoma; Bipolar Disorder; Brain; Brain Neoplasms; Carbamazepine; Dose-Response Relationship, Drug; Humans; Inositol; Lithium Chloride; Signal Transduction; Tritium; Tumor Cells, Cultured; Valproic Acid | 2000 |
Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells.
Topics: Amphetamine; Animals; Anthracenes; Antimanic Agents; Blotting, Western; Carbamazepine; Cell Line; Cell Survival; Chloramphenicol O-Acetyltransferase; Corticosterone; Dose-Response Relationship, Drug; Flavonoids; Gene Expression Regulation, Enzymologic; Imidazoles; Indoles; Inositol; Lithium; Maleimides; Protein Kinase C; Protein Kinase C-alpha; Pyridines; Receptors, Glucocorticoid; Tamoxifen; Tetradecanoylphorbol Acetate; Valproic Acid | 2004 |
Unlike lithium, anticonvulsants and antidepressants do not alter rat brain myo-inositol.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Brain Chemistry; Carbamazepine; Cerebral Cortex; Hippocampus; Inositol; Lamotrigine; Lithium Carbonate; Magnetic Resonance Spectroscopy; Male; Rats; Rats, Sprague-Dawley; Triazines; Valproic Acid | 2007 |
PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Carbamazepine; Chemotaxis; Humans; Inositol; Lithium Compounds; Phosphatidylinositol Phosphates; Signal Transduction; Valproic Acid | 2009 |
Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion.
Topics: Animals; Anticonvulsants; Antitubercular Agents; Autophagy; Carbamazepine; Cell Line; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Inositol; Macrophages; Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis; TOR Serine-Threonine Kinases; Tuberculosis; Zebrafish | 2015 |